<DOC>
	<DOCNO>NCT01062750</DOCNO>
	<brief_summary>Mesenchymal stem cell capability differentiate hepatocyte useful liver regeneration . Adipose tissue relatively enrich mesenchymal stem cell compare bone marrow tissue . In trial , eligible liver cirrhosis patient receive autologous adipose tissue derive stromal cell intrahepatic arterial catheterization .</brief_summary>
	<brief_title>Liver Regeneration Therapy Intrahepatic Arterial Administration Autologous Adipose Tissue Derived Stromal Cells</brief_title>
	<detailed_description>The population liver cirrhosis patient enormous Japan radical treatment liver transplantation : however , number give donor extremely limited . Mesenchymal stem cell capable differentiate mesodermal-lineage cell well endodermal-lineage cell hepatocytes . They reside mesenchymal tissue bone marrows well adipose tissue . The latter tissue relatively enrich mesenchymal stem cell compare bone marrow cell . In study , cirrhotic patient undergo intrahepatic arterial administration autologous adipose tissue derive stromal cell catheter .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>Criteria define implementation protocol</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Liver Cirrhosis</keyword>
</DOC>